ClinicalTrials.gov
public full text
Public Domain
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
This study evaluates the Impact of DihydroPyrimidine Dehydrogenase (DPD) activity on the efficacy of Capecitabine in patients with metastatic breast cancer. The DPD phenotype before the initiation of treatment will be assess and then the patient will be follow up during the treatment with Capecitabine up to 24 month.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)#867999
- Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer#842182
- ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere#1071886
- ModraDoc006/r in Patients With Breast Cancer#826283
- ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer#1125334
Record · ID 1101566
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive